SOD1 and hepatocellular carcinoma: The current study also found a substantial increase in antioxidant enzymes (CAT, SOD, GST, and GPx) following administration of nanocomposite loaded with sorafenib or nanocomposite alone against sorafenib as the conventional therapy for HCC.